US00287Y1091
US00287Y1091
AbbVie Inc.
Loading chart...
Financials
Trends
* Timeframes marked with (Est.) are analyst estimates based on consensus data.
Details
| Breakdown | 2025 | 2024 | Change % |
|---|---|---|---|
| Total Revenue | 61.160.000.000 | 56.334.000.000 | 8.6% |
| Cost of Revenue | 18.204.000.000 | 16.904.000.000 | 7.7% |
| Gross Profit | 42.956.000.000 | 39.430.000.000 | 8.9% |
| 22.865.000.000 | 27.536.000.000 | 17.0% | |
| Operating Income | 20.091.000.000 | 11.894.000.000 | 68.9% |
| Pretax Income | 6.597.000.000 | 3.716.000.000 | 77.5% |
| Net Income Common Stockholders | 4.186.000.000 | 4.238.000.000 | 1.2% |
| -- | -- | -- | |
| -- | -- | -- |